Updates from ASH22:  Aplastic Anemia and PNH with Emma Groarke, MD @AAMDSIF
Updates from ASH22:  Aplastic Anemia and PNH with Emma Groarke, MD  @AAMDSIF
Uploaded April 2026 | Updated September 2026, 1 day ago
Dr. Emma Groarke discusses research most relevant to patients reported over the past year on the biology and treatment on Aplastic Anemia and PNH. These studies were presented at the American Society of Hematology (ASH) 2022 meeting and their findings will be explained along with the potential impact of this research on understanding and treating aplastic anemia and PNH. This is an advanced scientific presentation. The final question and answer section is included in the recording.

For more information like this, try:
aamds.org/webinar/updates-aplastic-anemia-and-pnh-ash-2021-asco-2022-and-eha-2022-meetings
or
aamds.org/diseases/aplastic-anemia/treatment
or
aamds.org/diseases/pnh
Updates from ASH22:  Aplastic Anemia and PNH with Emma Groarke, MDCutaneous Graft versus Host Disease - Diagnosis and TreatmentPNH - 2022 San Antonio P&FVCUnderstanding Low Risk MDS 2021 Fall Patient Family ConferenceAAMDSIF 40th Anniversary Summit: Advances in the Science and Treatment of MDSAAMDSIF 40th Anniversary Summit: Advances in MDS, Myelodysplastic SyndromesMDS and Keeping Hope - Donnas StoryNon-Transplant Therapies for Marrow Failure with Carlos DeCastro, MD and Phil Scheinberg, MD, PhDHematopoietic Stem Cell TransplantationFDA Approval of PiaSky for Pediatric Patients with PNHManaging Treatment Symptoms with Diet with Joanna Myers Casale, RD, CSOTreatments for MDS and Secondary AML - Part 2, High-Risk
AAMDSIF |

Updates from ASH22: Aplastic Anemia and PNH with Emma Groarke, MD

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER